Association between the C-reactive protein-triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome - Takeaways - MDSpire

Association between the C-reactive protein-triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome

  • By

  • Cailin Feng

  • Jiasuer Alifu

  • Wen Zhang

  • Lu Liu

  • Guoqing Yin

  • Abdul-Quddus Mohammed

  • Fuad A. Abdu

  • Wenliang Che

  • July 1, 2026

  • 0 min

Share

  • 1

    The study included 421 chronic coronary syndrome patients undergoing coronary angiography to assess coronary microvascular dysfunction.

  • 2

    C-reactive protein-triglyceride-glucose index (CTI) was found to be independently associated with coronary microvascular dysfunction.

  • 3

    Higher CTI levels predicted an increased risk of major adverse cardiovascular events during a median follow-up of 35 months.

  • 4

    CTI demonstrated superior predictive accuracy for CMD-related major adverse cardiovascular events compared to the triglyceride-glucose index.

  • 5

    The findings support the use of CTI for early risk stratification in patients with suspected or confirmed microvascular dysfunction.

Original Source(s)

Association between the C-reactive protein-triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome

  • by Cailin Feng, Jiasuer Alifu, Wen Zhang, Lu Liu, Guoqing Yin, Abdul-Quddus Mohammed, Fuad A. Abdu, Wenliang Che

  • July 1, 2026

Related Content

Insulin resistance as a predictor of long-term adverse cardiovascular event risk in patients with atrial fibrillation following radiofrequency catheter ablation

Focal atrial tachycardia from the superior vena cava following atrial fibrillation cryoablation: a case report

Machine learning-based prediction of dataset-defined myocardial infarction risk: A retrospective computational study for precision cardiovascular risk assessment